Breast Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines

被引：121

作者：

Gradishar, William J. ^{[1
]}

Anderson, Benjamin O. ^{[2
]}

Balassanian, Ron ^{[3
]}

Blair, Sarah L. ^{[4
]}

Burstein, Harold J. ^{[5
]}

Cyr, Amy ^{[6
,7
]}

Elias, Anthony D. ^{[8
]}

Farrar, William B. ^{[9
,10
]}

Forero, Andres ^{[11
]}

Giordano, Sharon Hermes ^{[12
]}

Goetz, Matthew ^{[13
]}

Goldstein, Lori J. ^{[14
]}

Hudis, Clifford A. ^{[15
]}

Isakoff, Steven J. ^{[16
]}

Marcom, P. Kelly ^{[17
]}

Mayer, Ingrid A. ^{[18
]}

McCormick, Beryl ^{[15
]}

Moran, Meena ^{[19
]}

Patel, Sameer A. ^{[14
]}

Pierce, Lori J. ^{[20
]}

Reed, Elizabeth C. ^{[21
]}

Salerno, Kilin E. ^{[22
]}

Schwartzberg, Lee S. ^{[23
]}

Smith, Karen Lisa ^{[24
]}

Smith, Mary Lou ^{[25
]}

Soliman, Hatem ^{[26
]}

Somlo, George ^{[27
]}

Telli, Melinda ^{[28
]}

Ward, John H. ^{[29
]}

Shead, Dottie A. ^{[30
]}

Kumar, Rashmi ^{[30
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA

[3] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[4] UC San Diego Moores Canc Ctr, San Diego, CA USA

[5] Dana Farber Brigham & Womens Canc Ctr, Milford, MA USA

[6] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[7] Washington Univ, Sch Med, St Louis, MO 63130 USA

[8] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[9] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[10] Solove Res Inst, Columbus, OH USA

[11] Univ Alabama, Birmingham Comprehens Canc Ctr, Tuscaloosa, AL 35487 USA

[12] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[13] Mayo Clin, Ctr Canc, Rochester, MN USA

[14] Fox Chase Canc Ctr, Philadelphia, PA USA

[15] Mem Sloan Kettering Canc Ctr, New York, NY USA

[16] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[17] Duke Canc Inst, Durham, NC USA

[18] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[19] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[20] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[21] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[22] Roswell Pk Canc Inst, Buffalo, NY USA

[23] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[24] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[25] Res Advocacy Network, New York, NY USA

[26] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[27] City Hope Comprehens Canc Ctr, Duarte, CA USA

[28] Stanford Canc Inst, Stanford, CA USA

[29] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[30] Natl Comprehens Canc Network, Washington, DC USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2015年 / 13卷 / 12期

关键词：

PERTUZUMAB PLUS TRASTUZUMAB; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; PREOPERATIVE THERAPY; OVARIAN SUPPRESSION; 1ST-LINE TREATMENT; NEOADJUVANT; ANASTROZOLE; LETROZOLE; CHEMOTHERAPY;

D O I：

10.6004/jnccn.2015.0176

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.

引用

页码：1475 / 1485

页数：11

共 28 条

[1]

[Anonymous], 2007, J CLIN ONCOL, DOI DOI 10.1200/JCO.2006.09.2775

[2]

[Anonymous], CANC RES

[3] Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].

Baselga, Jose ;

Cortes, Javier ;

Kim, Sung-Bae ;

Im, Seock-Ah ;

Hegg, Roberto ;

Im, Young-Hyuck ;

Roman, Laslo ;

Pedrini, Jose Luiz ;

Pienkowski, Tadeusz ;

Knott, Adam ;

Clark, Emma ;

Benyunes, Mark C. ;

Ross, Graham ;

Swain, Sandra M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119

[4] Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer - The Pre-Operative "Arimidex" Compared to Tamoxilen (PROAC7) trial [J].

Cataliotti, L ;

Buzdar, AU ;

Noguchi, S ;

Bines, J ;

Takatsuka, Y ;

Petrakova, K ;

Dube, P ;

de Oliveira, CT .

CANCER, 2006, 106 (10) :2095-2103

[5] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].

Cortazar, Patricia ;

Zhang, Lijun ;

Untch, Michael ;

Mehta, Keyur ;

Costantino, Joseph P. ;

Wolmark, Norman ;

Bonnefoi, Herve ;

Cameron, David ;

Gianni, Luca ;

Valagussa, Pinuccia ;

Swain, Sandra M. ;

Prowell, Tatiana ;

Loibl, Sibylle ;

Wickerham, D. Lawrence ;

Bogaerts, Jan ;

Baselga, Jose ;

Perou, Charles ;

Blumenthal, Gideon ;

Blohmer, Jens ;

Mamounas, Eleftherios P. ;

Bergh, Jonas ;

Semiglazov, Vladimir ;

Justice, Robert ;

Eidtmann, Holger ;

Paik, Soonmyung ;

Piccart, Martine ;

Sridhara, Rajeshwari ;

Fasching, Peter A. ;

Slaets, Leen ;

Tang, Shenghui ;

Gerber, Bernd ;

Geyer, Charles E., Jr. ;

Pazdur, Richard ;

Ditsch, Nina ;

Rastogi, Priya ;

Eiermann, Wolfgang ;

von Minckwitz, Gunter .

LANCET, 2014, 384 (9938) :164-172

[6] Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review [J].

Dawood, Shaheenah ;

Broglio, Kristine ;

Buzdar, Aman U. ;

Hortobagyi, Gabriel N. ;

Giordano, Sharon H. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :92-98

[7] Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study [J].

Eiermann, W ;

Paepke, S ;

Appfelstaedt, J ;

Llombart-Cussac, A ;

Eremin, J ;

Vinholes, J ;

Mauriac, L ;

Ellis, M ;

Lassus, M ;

Chaudri-Ross, HA ;

Dugan, M ;

Borgs, M ;

Semiglazov, V .

ANNALS OF ONCOLOGY, 2001, 12 (11) :1527-1532

[8] Letrozole in the neoadjuvant setting: the P024 trial [J].

Ellis, Matthew J. ;

Ma, Cynthia .

BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (Suppl 1) :33-43

[9] Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype-ACOSOG Z1031 [J].

Ellis, Matthew J. ;

Suman, Vera J. ;

Hoog, Jeremy ;

Lin, Li ;

Snider, Jacqueline ;

Prat, Aleix ;

Parker, Joel S. ;

Luo, Jingqin ;

DeSchryver, Katherine ;

Allred, D. Craig ;

Esserman, Laura J. ;

Unzeitig, Gary W. ;

Margenthaler, Julie ;

Babiera, Gildy V. ;

Marcom, P. Kelly ;

Guenther, Joseph M. ;

Watson, Mark A. ;

Leitch, Marilyn ;

Hunt, Kelly ;

Olson, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2342-2349

[10] Phase III, randomized study of trastuzumab emtansine (T-DM1) ± pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study. [J].

Ellis, Paul Anthony ;

Barrios, Carlos H. ;

Eiermann, Wolfgang ;

Toi, Masakazu ;

Im, Young-Hyuck ;

Conte, Pier Franco ;

Martin, Miguel ;

Pienkowski, Tadeusz ;

Pivot, Xavier B. ;

Burris, Howard A. ;

Strasak, Alexander ;

Patre, Monika ;

Perez, Edith A. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 →